Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection. 1994

J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
April 2001, Gastroenterologie clinique et biologique,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
March 2014, Actas dermo-sifiliograficas,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
January 1998, Acta haematologica,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
March 1995, Journal of hepatology,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
November 2007, Multiple sclerosis (Houndmills, Basingstoke, England),
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
November 2002, Journal of hepatology,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
December 2001, Antiviral research,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
March 1993, The American journal of gastroenterology,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
January 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J M Durand, and E Cretel, and F Retornaz, and P Lefevre, and G Kaplanski, and J Soubeyrand
December 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!